[The patient's opinion matters: experience in the nutritional care in an ALS multidisciplinary team].
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease which has no cure, so the treatment will be symptomatic in a Multidisciplinary Unit. It is composed of professionals, experts in patient care, with an interdisciplinary vision in order to act in a coordinated manner depending on the different situations which may arise over the course of the disease. There are several studies showing improved survival in patients treated within the framework of a multidisciplinary team compared to treatment by isolated specialties. An ALS Multidisciplinary Unit was created in 2004 in the University Hospital of Bellvitge (HUB). It is composed of a neurologist, pulmonologist, nutritionist, endocrinologist, rehabilitation, physical therapist, psychologist, social worker, nurse manager, speech therapist and an administrative worker. To assess the impact of the multidisciplinary care of our program 418 patients diagnosed with ALS were evaluated, 84 patients who had been treated by general neurology and 334 who had been treated under a model of multidisciplinary care. Patients who were treated in the unit of multidisciplinary care had a median survival of 1246 days (IC 1109-1382), 104 days above the median 1148 days of those followed by a general neurology consultation (CI 998-1297). This difference was statistically significant (log-rank 10,8; p= 0.008). This benefit was independent of having received treatment with riluzole, non-invasive mechanical ventilation or percutaneous gastrostomy. Nutritional assessment was performed on the first visit and all subsequent controls. It is important to do anthropometric measurements and detect unintentional weight loss and its possible precipitating causes in order to establish the appropriate nutritional treatment. The exploration of dysphagia allows a determination of the appropriate dietary advice, the introduction of thickeners to adjust the texture of food or nutritional supplementation with high-calorie formulas to prevent or correct weight loss. If these measures are not sufficient or there is the risk of failure of respiratory function, early gastrostomy placement will be indicated. The analysis of 140 ALS patients (92 controls and 48 with radiologic percutaneous gastrostomy) showed no difference in mean survival time between groups (32 vs 33.9 months, log Rank 1.86 p=0.39). Any patient had major complications. Despite not find changes in survival, the use of gastrostomy should be understood as a treatment to improve the quality of life and well-being of the patient. Psychosocial support of the person and the family environment is essential to integrate all the changes and situations that arise in the course of the disease. This should start from diagnosis as early intervention contributes to improved training, preventing situations of deterioration and helping coping with the dependency process. It is also possible to use technology and social media to complement the classic care model. In the case of the HUB ALS Multidisciplinary Unit, affected individuals and their families have the resources of the Aula Paciente and ALS blog, created with the objective of providing opportunities for dialogue between patients, families and caregivers. The satisfaction degree of the patients with the care provided by the ALS Multidisciplinary Unit on service accessibility, information received and the quality of care was assessed globally as good in 52.8% or very good in 29, 2% of patients.


CONCLUSIONS
Attention for the ALS affected person must be considered within the framework of a multidisciplinary team made up of all the professionals who go to intervene throughout the disease process in order to provide increased survival with the best care and quality of life.
Unidad de Nutrición y Dietética, Servicio de Endocrinología y Nutrición. Hospital Universitari de Bellvitge (HUB).. mvirgili@bellvitgehospital.cat.
Inmaculada
I
Jiménez García
Fundación Catalana de Esclerosis Lateral Amiotrófica Miquel Valls.. mvirgili@bellvitgehospital.cat.
Núria
N
Sala Moya
Fundación Catalana de Esclerosis Lateral Amiotrófica Miquel Valls.. mvirgili@bellvitgehospital.cat.
Mariona
M
Riera Munt
Unidad de Nutrición y Dietética, Servicio de Endocrinología y Nutrición. Hospital Universitari de Bellvitge (HUB).. mvirgili@bellvitgehospital.cat.
Ma Verónica
MV
Herrera Rodríguez
Coordinadora Unidad Multidisciplinar. Servicio Neurologia. Hospital Universitari de Bellvitge (HUB). Unidad Multidisciplinar de ELA. Hospital Universitari de Bellvitge.. mvirgili@bellvitgehospital.cat.
Mónica
M
Povedano Panadés
Unidad de Nutrición y Dietética, Servicio de Endocrinología y Nutrición. Hospital Universitari de Bellvitge (HUB).. mvirgili@bellvitgehospital.cat.
Ma Núria
MN
Virgili Casas
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy*; D005190:Family; D006801:Humans; D044623:Nutrition Therapy / Q000379:methods*; D010348:Patient Care Team / Q000458:organization & administration*; D017060:Patient Satisfaction